AKT1 and familial pancreatic carcinoma: Consistently, the proportion of TUNEL and active Caspase-3 positive cells were increased (Fig. 5d), suggesting the Akt inhibitor renders pancreatic cancer cell sensitive to gemcitabine treatment.